← Leaderboards
Yi Zhang
Temple Univ Of The Commonwealth
$9,195,214
Attributed
$11,563,049
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,563,049 · 7
By mechanism
R01$11,209,558 · 6
R56$353,491 · 1
Top collaborators
- Jonathan A Soboloff6 shared
- Hai-Hui Xue2 shared
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Jonathan A Soboloff$8,227,450
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularT-LymphocyteAllogenicIsoimmunityImmunityT Cell ResponseSignal TransductionPathway InteractionsNovel StrategiesResponseMediatingCellsGenerationsProductionInflammatoryMalignant NeoplasmsLeadHematopoietic Stem Cell TransplantationGraft Versus Host Disease InductionGraft Vs Host DiseaseEpigenetic ProcessInsightBloodAntigens
Grant awards (23)
ID3 regulation of tissue-infiltrating T cells mediating graft-versus-host disease and leukemia rejection$733,555
R01 · FY2025 · CA · contact PI
ID3 regulation of tissue-infiltrating T cells mediating graft-versus-host disease and leukemia rejection$752,830
R01 · FY2024 · CA · contact PI
DOT1L, reconstitution of plasmacytoid dendritic cells and alloimmunity$620,832
R01 · FY2024 · HL · contact PI
DOT1L, reconstitution of plasmacytoid dendritic cells and alloimmunity$647,809
R01 · FY2023 · HL · contact PI
Synthetic rescue of antigen-driven T cells and alloimmunity$637,613
R01 · FY2023 · AI
DOT1L, reconstitution of plasmacytoid dendritic cells and alloimmunity$680,259
R01 · FY2022 · HL · contact PI
Synthetic rescue of antigen-driven T cells and alloimmunity$637,613
R01 · FY2022 · AI
DOT1L, reconstitution of plasmacytoid dendritic cells and alloimmunity$648,893
R01 · FY2021 · HL · contact PI
Synthetic rescue of antigen-driven T cells and alloimmunity$637,613
R01 · FY2021 · AI
Synthetic rescue of antigen-driven T cells and alloimmunity$643,676
R01 · FY2020 · AI · contact PI
Ezh2-mediated Epigenetic Effects and Alloimmunity$576,162
R01 · FY2019 · HL · contact PI
Synthetic rescue of antigen-driven T cells and alloimmunity$353,491
R56 · FY2019 · AI · contact PI
Synthetic rescue of antigen-driven T cells and alloimmunity$339,280
R01 · FY2019 · AI · contact PI
Ezh2-mediated Epigenetic Effects and Alloimmunity$587,990
R01 · FY2018 · HL · contact PI
Ezh2-mediated Epigenetic Effects and Alloimmunity$599,475
R01 · FY2017 · HL · contact PI
Delta-like ligand 4+ dendritic cells and induction of alloimmunity$323,700
R01 · FY2017 · CA · contact PI
Ezh2-mediated Epigenetic Effects and Alloimmunity$624,626
R01 · FY2016 · HL · contact PI
Delta-like ligand 4+ dendritic cells and induction of alloimmunity$323,700
R01 · FY2016 · CA · contact PI
Delta-like ligand 4+ dendritic cells and induction of alloimmunity$323,700
R01 · FY2015 · CA · contact PI
Delta-like ligand 4+ dendritic cells and induction of alloimmunity$226,864
R01 · FY2014 · CA · contact PI
Delta-like ligand 4+ dendritic cells and induction of alloimmunity$85,998
R01 · FY2014 · CA · contact PI
Delta-like ligand 4+ dendritic cells and induction of alloimmunity$322,663
R01 · FY2013 · CA · contact PI
Antigen Presenting Cells in the Induction of GVHD$234,707
R01 · FY2008 · CA · contact PI